Blog

Immunotherapy Slows Progression of Chronic Lymphocytic Leukemia – Specialty Pharmacy Times

Immunotherapy Slows Progression of Chronic Lymphocytic Leukemia
Specialty Pharmacy Times
A new immunotherapeutic strategy using 2 checkpoint inhibitors blocked the development of chronic lymphocytic leukemia (CLL) in preclinical stages and could serve as an effective method to restore anti-tumor immune response in patients with CLL

2018-05-09 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.